{
    "id": 932,
    "fullName": "RB1 R552*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RB1 R552* results in a premature truncation of the Rb1 protein within domain A at amino acid 552 of 928 (UniProt.org). Due to the loss of all known functional domains (UniProt.org), R552* is predicted to lead to a loss of Rb1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5925,
        "geneSymbol": "RB1",
        "terms": [
            "RB1",
            "OSRC",
            "p105-Rb",
            "p110-RB1",
            "pp110",
            "PPP1R130",
            "pRb",
            "RB"
        ]
    },
    "variant": "R552*",
    "createDate": "07/10/2014",
    "updateDate": "03/20/2019",
    "referenceTranscriptCoordinates": {
        "id": 147624,
        "transcript": "NM_000321",
        "gDna": "chr13:g.48381402C>T",
        "cDna": "c.1654C>T",
        "protein": "p.R552*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17667,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with metastatic ovarian cancer lacking PTEN expression did not respond to treatment with Ibrance (palbociclib), and was found to harbor RB1 R522* and CDK4 E184K, which potentially contributed to the lack of response (PMID: 31145688).",
            "molecularProfile": {
                "id": 32736,
                "profileName": "CDK4 E184K PTEN neg RB1 R552*"
            },
            "therapy": {
                "id": 850,
                "therapyName": "Palbociclib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 15724,
                    "pubMedId": 31145688,
                    "title": "Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31145688"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1013,
            "profileName": "RB1 R552*",
            "profileTreatmentApproaches": [
                {
                    "id": 4574,
                    "name": "HDAC Inhibitor",
                    "profileName": "RB1 R552*"
                }
            ]
        },
        {
            "id": 32736,
            "profileName": "CDK4 E184K PTEN neg RB1 R552*",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 147624,
            "transcript": "NM_000321",
            "gDna": "chr13:g.48381402C>T",
            "cDna": "c.1654C>T",
            "protein": "p.R552*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}